Toxoplasma gondii interferes with lipopolysaccharide-induced mitogen-activated protein kinase activation by

Leesun Kim1, Barbara A Butcher, Eric Y Denkers

  • 1Department of Microbiology and Immunology, Cornell University College of Veterinary Medicine, Ithaca, NY 14853, USA.

Insights

Toxoplasma gondii infection impairs macrophage response to LPS by inactivating mitogen-activated protein kinases (MAPKs). This mechanism differs from endotoxin tolerance, highlighting unique immune evasion strategies.

Area of Science:

  • Immunology
  • Cell Biology
  • Infectious Diseases

Background:

  • Toxoplasma gondii is an opportunistic parasite that infects macrophages.
  • Macrophage activation by lipopolysaccharide (LPS) is crucial for immune responses.
  • Mitogen-activated protein kinases (MAPKs) are key signaling molecules in macrophages.

Purpose of the Study:

  • To investigate the effect of Toxoplasma gondii infection on MAPK activation in mouse macrophages.
  • To compare the mechanisms of immune suppression by T. gondii with endotoxin tolerance.

Main Methods:

  • Infection of mouse macrophages with Toxoplasma gondii.
  • Stimulation of infected and uninfected macrophages with LPS.
  • Analysis of MAPK activation (p38, ERK1/2, JNK) and downstream signaling.
  • Measurement of cytokine production (TNF-alpha, IL-12).
  • Assessment of Toll-like receptor 4 (TLR4) expression.

Main Results:

  • T. gondii infection initially activated then deactivated MAPKs in macrophages.
  • Subsequent LPS triggering in infected cells showed defective MAPK activation, particularly p38 MAPK.
  • T. gondii infection impaired LPS-induced TNF-alpha and IL-12 production.
  • Mechanisms differed from endotoxin tolerance, with T. gondii up-regulating TLR4 while LPS down-regulated it.

Conclusions:

  • Toxoplasma gondii blocks LPS-triggered cytokine production in macrophages via MAPK inactivation.
  • These inhibitory pathways are distinct from those involved in endotoxin tolerance.
  • T. gondii employs unique strategies to evade host immune responses.